Marc Humbert

159.1k total citations · 28 hit papers
1.0k papers, 61.9k citations indexed

About

Marc Humbert is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Physiology. According to data from OpenAlex, Marc Humbert has authored 1.0k papers receiving a total of 61.9k indexed citations (citations by other indexed papers that have themselves been cited), including 838 papers in Pulmonary and Respiratory Medicine, 310 papers in Cardiology and Cardiovascular Medicine and 193 papers in Physiology. Recurrent topics in Marc Humbert's work include Pulmonary Hypertension Research and Treatments (726 papers), Cardiovascular Issues in Pregnancy (152 papers) and Asthma and respiratory diseases (144 papers). Marc Humbert is often cited by papers focused on Pulmonary Hypertension Research and Treatments (726 papers), Cardiovascular Issues in Pregnancy (152 papers) and Asthma and respiratory diseases (144 papers). Marc Humbert collaborates with scholars based in France, United States and United Kingdom. Marc Humbert's co-authors include Gérald Simonneau, Olivier Sitbon, David Montani, Xavier Jaïs, Peter Dorfmüller, Christophe Guignabert, Frédéric Perros, Philippe Hervé, Élie Fadel and Laurent Savale and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Marc Humbert

968 papers receiving 60.6k citations

Hit Papers

Mepolizumab Treatment in Patient... 1995 2026 2005 2015 2014 2006 2004 2004 2002 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma
    2014 1.6k citations Marc Humbert et al. profile →
  2. Pulmonary Arterial Hypertension in France
    2006 1.4k citations Marc Humbert, Olivier Sitbon et al. American Journal of Respiratory and Critical Care Medicine profile →
  3. Treatment of Pulmonary Arterial Hypertension
    2004 1.3k citations Marc Humbert, Olivier Sitbon et al. profile →
  4. Cellular and molecular pathobiology of pulmonary arterial hypertension
    2004 1.2k citations Marc Humbert et al. profile →
  5. Long-term intravenous epoprostenol infusion in primary pulmonary hypertension
    2002 1.0k citations Olivier Sitbon, Marc Humbert et al. profile →
  6. Riociguat for the Treatment of Pulmonary Arterial Hypertension
    2013 944 citations Marc Humbert et al. profile →
  7. Guidelines for the diagnosis and treatment of pulmonary hypertension
    2009 893 citations Marius M. Hoeper, Marc Humbert et al. European Respiratory Journal profile →
  8. Benefits of omalizumab as add‐on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE
    2004 839 citations Marc Humbert et al. profile →
  9. Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives
    2018 837 citations Marc Humbert, Peter Dorfmüller et al. European Respiratory Journal profile →
  10. Long-Term Response to Calcium Channel Blockers in Idiopathic Pulmonary Arterial Hypertension
    2005 797 citations Olivier Sitbon, Marc Humbert et al. Circulation profile →
  11. Inflammation and Immunity in the Pathogenesis of Pulmonary Arterial Hypertension
    2014 721 citations Marc Humbert et al. profile →
  12. Treatable traits: toward precision medicine of chronic airway diseases
    2016 653 citations Marc Humbert et al. European Respiratory Journal profile →
  13. Increased Interleukin-1 and Interleukin-6 Serum Concentrations in Severe Primary Pulmonary Hypertension
    1995 622 citations Marc Humbert, Olivier Sitbon et al. American Journal of Respiratory and Critical Care Medicine profile →
  14. A global view of pulmonary hypertension
    2016 591 citations Marius M. Hoeper, Marc Humbert et al. profile →
  15. Inflammation, Growth Factors, and Pulmonary Vascular Remodeling
    2009 557 citations Saadia Eddahibi, Marc Humbert et al. profile →
  16. Early detection of pulmonary arterial hypertension in systemic sclerosis: A French nationwide prospective multicenter study
    2005 520 citations Virginie Gressin, Marc Humbert et al. profile →
  17. Clinical and Molecular Genetic Features of Pulmonary Hypertension in Patients with Hereditary Hemorrhagic Telangiectasia
    2001 518 citations Marc Humbert et al. profile →
  18. Pathologic assessment of vasculopathies in pulmonary hypertension
    2004 511 citations Marc Humbert et al. profile →
  19. Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension
    2010 470 citations Marc Humbert, Olivier Sitbon et al. European Respiratory Journal profile →
  20. Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension
    2017 441 citations Jason Weatherald, Laurent Savale et al. European Respiratory Journal profile →
  21. Endothelial-to-Mesenchymal Transition in Pulmonary Hypertension
    2015 437 citations Benoît Ranchoux, Fabrice Antigny et al. Circulation profile →
  22. Pulmonary Arterial Hypertension
    2013 378 citations Pilar Escribano Subías, Andrew J. Peacock et al. profile →
  23. Genetics and Genomics of Pulmonary Arterial Hypertension
    2013 359 citations Marc Humbert et al. profile →
  24. Sotatercept for the Treatment of Pulmonary Arterial Hypertension
    2021 322 citations Marc Humbert, Vallerie V. McLaughlin et al. profile →
  25. Epidemiology and treatment of pulmonary arterial hypertension
    2017 317 citations Edmund Lau, Marc Humbert et al. profile →
  26. Post-acute COVID-19 syndrome
    2022 140 citations David Montani, Laurent Savale et al. profile →
  27. Pulmonary hypertension
    2024 132 citations Marc Humbert et al. profile →
  28. Pathology and pathobiology of pulmonary hypertension: current insights and future directions
    2024 43 citations Peter Dorfmüller, Marc Humbert et al. European Respiratory Journal profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marc Humbert France 123 48.9k 22.2k 12.5k 8.2k 7.7k 1.0k 61.9k
Gérald Simonneau France 116 48.1k 1.0× 30.4k 1.4× 4.2k 0.3× 10.0k 1.2× 7.9k 1.0× 567 58.8k
Hossein Ardeschir Ghofrani Germany 86 27.9k 0.6× 17.9k 0.8× 4.0k 0.3× 4.5k 0.5× 3.5k 0.5× 635 34.8k
Rubin M. Tuder United States 98 20.6k 0.4× 5.4k 0.2× 5.0k 0.4× 2.0k 0.2× 4.0k 0.5× 330 33.1k
Murray F. Brennan United States 143 43.3k 0.9× 9.1k 0.4× 4.4k 0.4× 870 0.1× 31.6k 4.1× 954 81.0k
Amir Lerman United States 107 8.3k 0.2× 27.2k 1.2× 7.3k 0.6× 1.4k 0.2× 15.0k 2.0× 881 51.0k
David Cunningham United Kingdom 120 30.7k 0.6× 2.6k 0.1× 2.1k 0.2× 3.0k 0.4× 24.5k 3.2× 1.2k 77.9k
Andreas M. Zeiher Germany 139 5.2k 0.1× 17.8k 0.8× 10.6k 0.8× 9.6k 1.2× 17.6k 2.3× 564 69.3k
Lilach O. Lerman United States 84 7.0k 0.1× 7.9k 0.4× 4.0k 0.3× 1.8k 0.2× 6.5k 0.9× 674 29.6k
Kazuaki Chayama Japan 99 9.8k 0.2× 3.9k 0.2× 2.1k 0.2× 1.0k 0.1× 10.7k 1.4× 1.4k 45.3k
Cynthia S. Crowson United States 87 6.2k 0.1× 2.8k 0.1× 3.6k 0.3× 2.1k 0.3× 4.7k 0.6× 476 28.1k

Countries citing papers authored by Marc Humbert

Since Specialization
Citations

This map shows the geographic impact of Marc Humbert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Humbert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Humbert more than expected).

Fields of papers citing papers by Marc Humbert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc Humbert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Humbert. The network helps show where Marc Humbert may publish in the future.

Co-authorship network of co-authors of Marc Humbert

This figure shows the co-authorship network connecting the top 25 collaborators of Marc Humbert. A scholar is included among the top collaborators of Marc Humbert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc Humbert. Marc Humbert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Montani, David, Vallerie V. McLaughlin, J. Simon R. Gibbs, et al.. (2025). Consistent Safety and Efficacy of Sotatercept for Pulmonary Arterial Hypertension in BMPR2 Mutation Carriers and Noncarriers: A Planned Analysis of a Phase II, Double-Blind, Placebo-controlled Clinical Trial (PULSAR). American Journal of Respiratory and Critical Care Medicine. 211(6). 1028–1037. 3 indexed citations
2.
Humbert, Marc, et al.. (2024). Association Between Peripheral Blood Eosinophils Count and Mortality in Respiratory Infections. Archivos de Bronconeumología. 60(9). 590–592. 1 indexed citations
3.
Lecerf, Florence, Olivier Sitbon, David Montani, et al.. (2024). 4D flow cardiac MRI to assess pulmonary blood flow in patients with pulmonary arterial hypertension associated with congenital heart disease. Diagnostic and Interventional Imaging. 105(7-8). 266–272. 5 indexed citations
4.
Fadel, Élie, Benoît Gérardin, Dominique Fabre, et al.. (2024). Balloon pulmonary angioplasty for proximal chronic thromboembolic pulmonary hypertension in patients ineligible for pulmonary endarterectomy. Pulmonary Circulation. 14(3). e12432–e12432. 1 indexed citations
5.
Humbert, Marc, et al.. (2023). Pulmonary Veno-Occlusive Disease. Advances in Pulmonary Hypertension. 22(4). 164–169. 1 indexed citations
6.
Perros, Frédéric, Étienne-Marie Jutant, Laurent Savale, et al.. (2023). Physiopathologie et traitements de l’hypertension artérielle pulmonaire. médecine/sciences. 39(4). 359–369. 2 indexed citations
7.
Chemla, D. S., Emmanuelle Berthelot, Jason Weatherald, et al.. (2021). The isobaric pulmonary arterial compliance in pulmonary hypertension. ERJ Open Research. 7(2). 941–2020. 6 indexed citations
8.
Perros, Frédéric, David Boulate, Tom Kotsimbos, et al.. (2019). Smooth Muscle Phenotype in Idiopathic Pulmonary Hypertension: Hyper-Proliferative but not Cancerous. International Journal of Molecular Sciences. 20(14). 3575–3575. 16 indexed citations
9.
Bisserier, Malik, Carlos Bueno‐Betí, Guillaume Bonnet, et al.. (2019). A novel secreted-cAMP pathway inhibits pulmonary hypertension via a feed-forward mechanism. Cardiovascular Research. 116(8). 1500–1513. 18 indexed citations
10.
Seferian, Andrei, Xavier Jaïs, Mitja Jevnikar, et al.. (2019). Klippel-Trenaunay syndrome as a rare cause of chronic thromboemboembolic pulmonary hypertension. Respiratory Medicine and Research. 76. 48–53. 5 indexed citations
11.
Dumas, Sébastien J., Gilles Bru‐Mercier, Audrey Courboulin, et al.. (2018). NMDA-Type Glutamate Receptor Activation Promotes Vascular Remodeling and Pulmonary Arterial Hypertension. Circulation. 137(22). 2371–2389. 80 indexed citations
12.
Weatherald, Jason, Laurent Savale, & Marc Humbert. (2017). Medical Management of Pulmonary Hypertension with Unclear and/or Multifactorial Mechanisms (Group 5): Is There a Role for Pulmonary Arterial Hypertension Medications?. Current Hypertension Reports. 19(11). 86–86. 10 indexed citations
13.
Rincheval, Vincent, Bernard Mignotte, Sylvain Richard, et al.. (2015). Inactivation of p53 Is Sufficient to Induce Development of Pulmonary Hypertension in Rats. PLoS ONE. 10(6). e0131940–e0131940. 42 indexed citations
14.
Ranchoux, Benoît, Fabrice Antigny, Catherine Rücker‐Martin, et al.. (2015). Endothelial-to-Mesenchymal Transition in Pulmonary Hypertension. Circulation. 131(11). 1006–1018. 437 indexed citations breakdown →
15.
Sattler, C.H., Hélène Bouvaist, Xavier Jaïs, et al.. (2013). Outcome of candidates for liver transplantation suffering from portopulmonary hypertension. European Respiratory Journal. 42(Suppl 57). P2616–P2616. 1 indexed citations
16.
Vitari, Claudio, et al.. (2012). Les spécificités de la communauté francophone d'enseignant-chercheurs en Système d'information en termes de prestige des revues et de publications. Systèmes d information & management. Volume 17(4). 69–95. 6 indexed citations
17.
Sassi, Yassine, Christelle Guibert, Peter Dorfmüller, et al.. (2011). Inhibition of MRP4 prevents and reverses pulmonary hypertension in mice. Journal of Clinical Investigation. 121(7). 2888–2897. 84 indexed citations
18.
Hoeper, Marius M., et al.. (2009). Guidelines for the diagnosis and treatment of pulmonary hypertension. European Respiratory Journal. 34(6). 1219–1263. 893 indexed citations breakdown →
19.
Sitbon, Olivier, Virginie Gressin, Rudolf Speich, et al.. (2004). Bosentan for the Treatment of Human Immunodeficiency Virus–associated Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine. 170(11). 1212–1217. 180 indexed citations
20.
Eddahibi, Saadia, Marc Humbert, Saı̈d Sediame, et al.. (2000). Imbalance between Platelet Vascular Endothelial Growth Factor and Platelet-derived Growth Factor in Pulmonary Hypertension. American Journal of Respiratory and Critical Care Medicine. 162(4). 1493–1499. 83 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gérald Simonneau Breakdown of academic impact, for papers by Hossein Ardeschir Ghofrani Breakdown of academic impact, for papers by Rubin M. Tuder Breakdown of academic impact, for papers by Murray F. Brennan Breakdown of academic impact, for papers by Amir Lerman Breakdown of academic impact, for papers by David Cunningham Breakdown of academic impact, for papers by Andreas M. Zeiher Breakdown of academic impact, for papers by Lilach O. Lerman Breakdown of academic impact, for papers by Kazuaki Chayama Breakdown of academic impact, for papers by Cynthia S. Crowson
Rankless by CCL
2026